References
- Bontha S, Kabanov AV, Bronich TK. Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. J Control Release 2006; 114: 163–74
- Chen Y, Yang H, Lu B, Li M, Zong TL. Preparation of lung-targeting cis-dichlorodiammineplatinum niosomes and evaluation of their characteristics in vitro. J West China Pharm Sci 2008; 23(2)129–32
- Grunberg E, Chassan JB, Hines LR. Relationship between change in body weight and weight of tumor: A contrast between tumor systems in mice. Chemotherapy 1965; 10(5)269–76
- Gryparis EC, Hatziapostolou M, Papadimitriou E, Avgoustakis K. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNC prostate cancer cells. Eur J Pharm Biopharm 2007; 67: 1–8
- Gupta PK, Hung CT, Perrier DG. Quantization of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci 1987; 76: 141–5
- Hao YM, Zhao FL, Li N, Yang YH, Li KA. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002; 244: 73–80
- Huo D, Deng S, Li L, Ji J. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm 2005; 289: 63–7
- Lawrence MJ. Formation, characterization and stability of nonionic surfactant vesicles. STP Pharm Sci 1996; 6(1)49–60
- Liu Y, Gao WG, Liu WP. Study on the photostability of cisplatin injection. Chin Pharm Affairs 2005; 19(10)613–14
- Lu B. New techniques and new dosage forms of drugs2nd. Publishers of People's Health, Beijing 2005; 55–65
- Lu B, Xiong SB, Yang H, Yin XD, Chao RB. Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases II: Tissue distribution and pharmacokinetics. Int J Pharm 2006; 307(2)175–81
- Lu B, Zhang ZQ. Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: Their preparation, release behavior and therapeutic efficiency against colonic cancer. J Pharm Sci 2006; 95(12)2619–30
- Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: A comparative study between liposomes and niosomes. J Microencapsul 2008; 25(7)499–512
- Ozer AY, Boustra JA. A novel drug delivery system: Non-ionic surfactant vesicles. Eur J Pharm Biopharm 1991; 37: 75–9
- Peleg-Shulman T, Gibson D, Cohen R, Abra R, Barenholz Y. Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance. Biochim Biophys Acta 2001; 1510: 278–91
- Pi FM, Tu XD, Wu Y. Preparation of ATP-2Na loaded liposome and its effect on tissues energy state in myocardial ischemic mice. Acta Pharm Sin 2010; 45(10)1322–6
- Rentel CO, Bouwstra JA, Naisbett B, Junginger HE. Niosomes as a novel peroral vaccine delivery system. Int J Pharm 1999; 186: 161–7
- Song SL, Liu JJ, Huang G, Wang ZH, Song YY, Sun XG, Chen T. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model. J Nucl Med 2008; 49(2)303–9
- Sun Y. Handbook of anticancer drugs. Medical Publishers of Beijing University, Beijing 2007; 13–15
- Townsend DM, Hanigan MH. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J Pharmacol Exp Ther 2002; 300: 142–8
- Wang ZM, Ren ZG, Ye D. Metastatic characteristics of rabbit liver VX2 cancer model. Cancer 2006; 26(1)1057–8
- Wang X, Zhang JC, Zhu GY. Elementary oncology and outline of therapeutics. Publishing House of 2nd Medical University of PLA, Shanghai 2001; 243–5
- Zhang M, Hou SX, Gong T, Chen YH, Liao GT. Derivative assay of bovine serum albumin microspheres loaded cisplatin for pulmonary targeting. China J Pharm 1994; 29(6)355–7